CohBar的股东预计将持有约15%的CohBar普通股,合并前的Morphogenesis股东预计将持有约77%的CohBar普通股。
CohBar还与Morphogenesis现有投资者的关联公司签署了一...查看全文
蹊之美股生物医药2021-08-12 21:30
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
CohBar (NASDAQ:CWBR)+25%Allied Healthcare Products (NASDAQ:AHPI)+18%Doximity (NYSE:DOCS)+33%Orphazyme (NASDAQ:ORPH) +16%Fulcrum Therapeutics (NASDAQ:FULC) +7%
Losers:
Biodesix...查看全文
蹊之美股生物医药2021-08-12 03:30
作者:王医生
微信公众号:蹊之美股生物医药 / CaesarBiotech
标的公司:CohBar, Inc. (NASDAQ:CWBR)
CohBar, Inc. (CWBR) 是一家临床阶段的生物技术公司,开发基于线粒体的疗法来治疗慢性疾病和延长健康寿命,该公司今天宣布了多中心、随机、双盲、安慰剂对照的 1a/1b 期临床试...查看全文
$CohBar(CWBR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-21-023262 Size: 5 KB 网页链接
$CohBar(CWBR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-21-023263 Size: 5 KB 网页链接
$CohBar(CWBR)$ 8-K Current report, item 5.02 Accession Number: 0001213900-21-022974 Act: 34 Size: 34 KB 网页链接
$CohBar(CWBR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-21-018676 Act: 34 Size: 116 KB 网页链接
$CohBar(CWBR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-21-018680 Act: 34 Size: 3 MB 网页链接
$CohBar(CWBR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-21-010340 Size: 8 KB 网页链接
$CohBar(CWBR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-21-007733 Act: 34 Size: 61 KB 网页链接
$CohBar(CWBR)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-000357 Act: 33 Size: 1 KB 网页链接
$CohBar(CWBR)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001213900-21-003718 Act: 33 Size: 322 KB 网页链接
$CohBar(CWBR)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-21-000660 Act: 33 Size: 101 KB 网页链接